PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Oct-2021 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Business and Progress of Varoglutamstat Clinical Development in Alzheimer's Disease (news with additional features) Vivoryon Therapeutics N.V.
17-Oct-2021 SMi's 4th Annual Ophthalmic Drugs Conference - Chairman's Invitation Released Ophthalmic Drugs
15-Oct-2021 Swiss Takeover Board confirms Absence of an Obligation to make a Public Takeover Offer in connection with planned Enbiotix Merger Polyphor AG
15-Oct-2021 Relief Reports U.S. Collaboration Partner Announces Journal of Infectious Diseases and Treatment Publishes Positive Aviptadil Data in High Comorbidity Critical COVID-19 Patients w/ Respiratory Failure RELIEF THERAPEUTICS Holding AG
14-Oct-2021 Drägerwerk AG & Co. KGaA: In the third quarter, net sales and EBIT were below the strong prior-year level. Overall strong business performance in the first nine months. Outlook confirmed. Drägerwerk AG & Co. KGaA
14-Oct-2021 Exelixis and STORM Therapeutics Enter into Exclusive Collaboration and License Agreement to Discover and Develop Inhibitors of Novel RNA Modifying Enzymes Exelixis
14-Oct-2021 Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM) Tetra Bio-Pharma Inc.
14-Oct-2021 Lundbeck receives exclusive rights to APB-A1, an innovative phase I-ready bio-therapeutic for the treatment of neuroimmune diseases from AprilBio Lundbeck
14-Oct-2021 Anticancer Bioscience Welcomes New Investor into Seed Financing Round Bringing Total Raised to Over $31m to Advance Synthetic Lethality Approaches to Cancer Therapy Anticancer Bioscience (ACB)
14-Oct-2021 aap's transformation continues: Marc Langner strengthens Supervisory Board aap Implantate AG
13-Oct-2021 Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm Pharmalex
13-Oct-2021 Bionabu Launches Secure Collaboration Platform for Health and Life Sciences Professionals to Connect and Network Bionabu
13-Oct-2021 Actimed Therapeutics Continues to Strengthen Intellectual Property Portfolio with Newly Granted US and Canadian Patents Actimed Therapeutics
13-Oct-2021 New long-term data reinforcing promising safety and efficacy profile of brain-penetrant tolebrutinib presented at ECTRIMS 2021 Sanofi
13-Oct-2021 BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery BD (Becton, Dickinson and Company)
13-Oct-2021 Cellumed and ARTES Sign Development and License Agreement Cellumed
13-Oct-2021 Cellumed and ARTES Sign Development and License Agreement B3C newswire
13-Oct-2021 Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene Therapy Merck Group
13-Oct-2021 CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation CureVac
13-Oct-2021 BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery B3C newswire